Providing value-driven pharmaceuticals in healthcare
The world's most comprehensive policy review forum
Experts in market access, pricing and health policy will provide delegates with the most comprehensive review of the US health reform.
This event will examine new strategies to control drug costs and reduce budget deficits whilst widening patient access. You will hear a balanced discussion between industry and public, private sector payers.
Sponsors
Presentation sponsors
Presentation sponsors
Come to Market Access World USA 2012 to learn
- the impact of reimbursement models on market access
- how will CER differ from the EU HTA experience
- HTA agency policy and practice globally
- how the US economy will impact state Medicaid programs
- the impact of changing incentive structures
Who should attend
- Health Policy
- Market Access
- Pricing & Reimbursement
- Health Economics/Outcomes
- HTA/Comparative Effectiveness
- Evidence Based Medicine
- Pharmacoeconomics
- Chief Pharmacy Officers
- Chief Medical Officers
- Marketing
- Medical Affairs
- Government, Payer & Stakeholder relations
World class solution providers attend to
- Position their products and services in front of decision makers from major pharma and biotech companies
- Meet and do business with senior execs within the pharmaceutical market access and pricing reimbursement community
- Position themselves as a thought leader
- Generate leads and new business
Who should sponsor
- CRO’s
- Niche CRO’s
- IT/Software/Data Providers
- Consultants
- Communications
- Legal
Sponsors
Presentation sponsors
Presentation sponsors
